Authors contributions Conceptualization and methodoloy preparation, project administration, writing original draft: Kobayashi H Software preparation: Kobayashi H, Matsubara S, Yoshimoto C, Imanaka S Validation: Yoshimoto C, Shigetomi H, Imanaka S Formal analysis and investigation: Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S Resources provided and supervision: Matsubara S Data curation: Matsubara S, Kobayashi H Writing, review, editing and visualization: Kobayashi H, Matsubara S, Yoshimoto C, Shigetomi H, Imanaka S Funding acquisition: Yoshimoto C Availability of data and materials Not applicable
You may need to lessen your dosage for your next dose in order to minimize risk and/or severity of potential side effects
GST M1 polymorphism associates with DNA oxidative damage and mortality among hemodialysis patients
Kosiborod and his team explored data from 616 obese patients with symptomatic HFpEF
In this real-world study cohort, LAAO with Watchman revealed an excellent safety profile with no post-procedure complications
Hormone replacement therapy It is used to treat individuals with GH deficiency in older adults and people with some medical conditions